Classification of isolated tumor cells and micrometastasis

Cancer

Volumn 86, Issue 12, 1999, Pages 2668-2673

  Hermanek, Paul ^a   Hutter, Robert V P ^b   Sobin, Leslie H ^c   Wittekind, Christian ^d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b SAINT BARNABAS MEDICAL CENTER   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Circulating tumor cells; Disseminated tumor cells; Isolated tumor cells; Micrometastasis; Peritoneal cytology; Pleural cytology; TNM classification

Indexed keywords

ARTICLE; ASCITES FLUID CYTOLOGY; CANCER STAGING; CELL ISOLATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG LAVAGE; LYMPH NODE CELL; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL; TUMOR CLASSIFICATION; ASCITES FLUID; CLASSIFICATION; CYTODIAGNOSIS; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; PATHOLOGY; PLEURA EFFUSION; TUMOR EMBOLISM;

ASCITIC FLUID; CYTODIAGNOSIS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PLEURAL EFFUSION, MALIGNANT; PROGNOSIS;

EID: 0033573070     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991215)86:12<2668::AID-CNCR11>3.0.CO;2-R     Document Type: Article

References (51)

1. Sanson M. Fait remarkable de diathèse cancereuse. Gaz Med de Paris 1834;2:140. Cited by Papac R. Bone marrow metastases. Cancer 1994;74:2403-13.
2. Sanson M. Fait remarkable de diathèse cancereuse. Gaz Med de Paris 1834;2:140. Cited by Papac R. Bone marrow metastases. Cancer 1994;74:2403-13.
3. Ashwort TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust Med J 1896;14:146. Cited by Abati A, Liotta LA. Looking forward in diagnostic pathology. The molecular superhighway. Cancer 1996;78:1-3.
4. Ashwort TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust Med J 1896;14:146. Cited by Abati A, Liotta LA. Looking forward in diagnostic pathology. The molecular superhighway. Cancer 1996;78:1-3.
5. Ryall C. The technique of cancer operations, with reference to the danger of cancer infection. BMJ 1908;2:1005-8.
6. Christopherson W. Cancer cells in the peripheral blood: a second look. Acta Cytol 1965;9:169-74.
7. Tarin D. Cancer metastasis. In: Peckham M, Pinedo H, Veronesi U, editors. Oxford textbook of oncology.. Oxford: Oxford University Press, 1995:118-32.
8. Fidler IJ, Molecular biology of cancer: invasion and metastasis. In: DeVita VT Jr., Hellmann S, Rosenberg SA, editors. Cancer: Principles and practice of oncology. 5th edition. Philadelphia: Lippincott-Raven Publishers, 1997:135-52.
9. Abati A, Liotta LA. Looking forward in diagnostic pathology. The molecular superhighway. Cancer 1996;78:1-3.
10. Yamamoto N, Kato Y, Yanagisawa A, Ohta H, Takahashi T, Kitagawa T. Predictive value of genetic diagnosis for cancer micrometastasis. Cancer 1997;80:1393-98.
11. Oberneder R, Kriegmair M, Pantel K, Staudte A, Hofstetter A, Riethmüller G. Prognostic relevance of micrometastatic tumor cells in bone marrow of patients with genitourinary tract tumors. J Urol 1994;151:413A.
12. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 1993;85:1419-24.
13. Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 1996;88:1652-64.
14. Wells CA, Heryet A, Brochier J, Gatter KC, Mason DY. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer 1984;50:193-7.
15. Stosiek P, Gerber B, Kasper M. Zur prognostischen Bedeutung von Mikrometastasen in axillären Lymphknoten beim Mammakarzinom. Pathologe 1996;17:433-9.
16. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma. Cancer 1997;80:1188-97.
17. Juhl H, Stritzel M, Wroblewski A, Henne-Bruns D, Kremer B, Schmiegel W, et al. Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 1994;57:330-5.
18. Fellbaum Ch, Kestlmeier R, Busch R, Böttcher K, Siewert JR, Höfler H. Prognostic relevance of microcarcinosis ("microinvolvement") in lymph nodes in gastric cancer. In: Siewert JR, Roder JD, editors. Progress in gastric cancer research 1997. Bologna, Italy: Monduzzi Editore, 1997:235-6.
19. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC 49. Cancer 1994;73:563-9.
20. Jeffers MD, O'Dowd GNI, Mulcahy H, Stagg M, O'Donoghue DP, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994;172:183-7.
21. Liefers GJ, Cleton-Jansen AM, van De Velde CJH, Hermans J, van Krieken JHJM, Cornelisse CJ, et al. Micrometastasis and survival in stage II colorectal cancer. N Engl J Med 1998;339: 223-8.
22. Edelstein RA, Zietman AL, de las Morenas A, Krane RJ, Babayan RK, Dallow KC, et al. Implications of prostate micrometastasis in pelvic lymph nodes: an archival tissue study. Urology 1996;47:370-5.
23. Pantel K, Izbicki J, Passlick B, Angstwurm M, Häussinger K, Thetter O, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996;347:649-53.
24. Passlick B, Izbicki JR, Kubuschok B, Thetter O, Pantel K. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg 1996;61: 177-83.
25. Hosch StB, Knoefel WT, Metz S, Stoecklein N, Niendorf A, Broelsch ChE, et al. Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas 1997;15:154-9.
26. Demeure MJ, Doffek KM, Komorowski RA, Wilson SD. Adenocarcinoma of the pancreas. Detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay. Cancer 1998;83:1328-34.
27. Thorban S, Roder JD, Nekarda H, Funk A, Pantel K, Siewert JR. Disseminated epithelial tumor cells in bone marrow of patients with esophageal cancer: detection and prognostic significance. World J Surg 1996;20:567-73.
28. Izbicki JR, Hosch StB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997;337:1188-94.
29. Glickman JN, Torres C, Wang HH, Turner JR, Shahsafaei A, Richards WG, et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999;85:769-78.
30. Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH, editors. International Union Against Cancer. Prognostic factors in cancer. Berlin: Springer, 1995:50, 68.
31. Funke I, Schraut W. Meta-analysis of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 1998;16:557-66.
32. Keshtgar MRS, Waddington WA, Lakhani SR, Ell PJ. The sentinel node in surgical oncology. Berlin: Springer, 1999.
33. Czerniecki BJ, Scheff AM, Callans LS, Spitz FR, Bedrosian I, Conant EF, et al. Immunohistochemistry with pancytokeratins improve the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999;85:1098-103.
34. Veronesi U. The sentinel node and breast cancer. Br J Surg 1999;86:1-2.
35. Pantel K, Cote RJ. New strategies in minimal residual cancer. Inpharma Weekly Suppl 1998;1:3-6.
36. Riethmüller G, Schneider-Gädicke E, Schlimok G, Schmiegel W, Raab R, Höffken K, et al. Randomized trial of monocolonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 1994;343:1177-88.
37. Riethmüller G, Holz E, Schlimok G, Schmiegel W, Raab R, Höffken K, et al. Monoclonal antibody therapy for resected Dukes' C colorectal cancer. J Clin Oncol 1998;16:1788-97.
38. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.
39. Schlimok G, Funke I, Bock B, Schweiberer B, Witte J, Riethmüller G. Epithelial tumor cells in bone marrow of patients with colorectal cancer. J Clin Oncol 1990;8:831-7.
40. Sobin LH. Frequently asked questions regarding the application of the TNM classification. Cancer 1999;85:1405-6.
41. Hermanek P, Henson DE, Hutter RW, Sobin LH, editors. International Union Against Cancer. TNM supplement 1993. A commentary on uniform use. Berlin: Springer, 1993:7, 14.
42. Nakajima T, Harashima S, Hirata M, Kajitani T. Prognostic and therapeutic value of peritoneal cytology in gastric cancer. Acta Cytol 1978;22:225-9.
43. Martin JK Jr., Goellner JR. Abdominal fluid cytology in patients with gastrointestinal malignant lesions. Mayo Clin Proc 1986;61:467-71.
44. Maruyama K. Diagnosis of invisible peritoneal metastasis: cytologic examination by peritoneal lavage. In: Cordiano C, de Manzoni G, editors. Staging and treatment of gastric cancer. Padua, Italy: Piccin Nuova Libraria, 1991:180-1.
45. Warshaw AL. Implication of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 1991;161:26-30.
46. Leather AJM, Kocjan G, Savage F, Hu W, Yiu C-Y, Boulos PB, et al. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum 1994;37:814-9.
47. Nekarda H, Schenck U, Luswig C, Stark M, Becker K, Fink U, et al. Prognosis of free abdominal cancer cells in totally resected gastric cancer. Eur J Surg Oncol 1994;20:361.
48. Broll R, Lembcke K, Stock C, Zingler M, Duckrow M, Schimmelpfennig H, et al. Tumorzelldissemination in das Knochenmark und in die Peritonealhöhle. Langenbecks Arch Chir 1996;381:51-8.
49. Uras C, Altinkaya E, Yardimci H, Goksel S, Yaruz N, Kaptanoglu L, et al. Peritoneal cytology in the determination of free tumor cells within the abdomen in colon cancer. Surg Oncol 1996;5:259-63.
50. Buhr J. Tumor cells in intraoperative pleural lavage. Cancer 1990;65:1801-4.
51. Shimotakahara T, Aikon T, Nishijima H, Matsumoto H, Yanagi M, Ogawa H, et al. The significance of tumor cells in intraoperative pleural lavage: an indicator for the poor prognosis of lung cancer and therapy. In: Antypos G, editor. Second International Congress on Lung Cancer. Bologna, Italy: Monduzzi Editore, 1996:369-73.